HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 21 November 2011

Recently published CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  40 papers were listed this time. Here's a handful in our areas of research interest:

Tunis SL. Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings. Appl Health Econ Health Policy. 2011 Nov 1;9(6):351-65. PubMed PMID: 21892840.

Scotland G, Waugh N, Royle P, et al. Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal. Pharmacoeconomics. 2011 Nov 1;29(11):951-61. PubMed PMID: 21854080.

Price D, Gray A, Gale R, et al. Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD. Respir Med. 2011 Nov;105(11):1635-47. Epub 2011 Jul 20. PubMed PMID: 21764277.

Campbell HE, Epstein D, Bloomfield D, et al. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. Eur J Cancer. 2011 Nov;47(17):2517-30. Epub 2011 Jul 7. PubMed PMID: 21741831.